Combination of Peroxisome Proliferator-Activated Receptor Α/Γ Agonists May Benefit Type 2 Diabetes Patients With Coronary Artery Disease Through Inhibition of Inflammatory Cytokine Secretion
Experimental and Therapeutic Medicine - Greece
doi 10.3892/etm.2013.891
Full Text
Open PDFAbstract
Available in full text
Date
January 10, 2013
Authors
Publisher
Spandidos Publications